Northwestern University researchers have reported a novel injectable nanomaterial that crossed the blood–brain barrier and ...

Please provide your email address to receive an email when new articles are posted on . Among patients who required interhospital transfer for STEMI, nearly 40% had cath lab activation times of less ...

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke. As many as one in four people ...

CHICAGO, IL—Low-dose coronary alteplase infused early after PCI does not reduce the likelihood of microvascular obstruction (MVO) in ST-segment elevation MI, the T-Time trial suggests. Colin Berry, MD ...

Please provide your email address to receive an email when new articles are posted on . Among patients with cancer who experienced a stroke, reperfusion therapy conferred similar short-term outcomes ...

Under ischemic conditions, the deficiency of oxygenated blood supply to the myocardium makes the energy requirements of the heart impossible to satisfy. Several metabolic alterations derive from ...

Intravenous infusion of alteplase is used for thrombolysis before endovascular thrombectomy for ischemic stroke. Tenecteplase, which is more fibrin-specific and has longer activity than alteplase, is ...